Schond L. Greenway

Insider Reports History

Location
Rockville, MD
Signature
/s/ Mark Sullivan, Attorney-in-Fact for Schond Greenway
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Schond L. Greenway:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mind Medicine (MindMed) Inc. Chief Financial Officer Common Shares 211,057 $2,064,137 $9.78 25 Mar 2024 Direct
Avalo Therapeutics, Inc. CFO Common Stock 3,883 $2,017 $0.5194 10 Dec 2021 Direct
Mind Medicine (MindMed) Inc. Chief Financial Officer Stock Option (Right to Buy) 150,000 27 Feb 2024 Direct

Insider Reports Filed by Schond L. Greenway

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNMD Mind Medicine (MindMed) Inc. 25 Mar 2024 1 -$54,377 4 Chief Financial Officer 26 Mar 2024, 17:16
MNMD Mind Medicine (MindMed) Inc. 27 Feb 2024 1 $0 4 Chief Financial Officer 29 Feb 2024, 16:45
MNMD Mind Medicine (MindMed) Inc. 26 Dec 2023 1 -$20,517 4 Chief Financial Officer 26 Dec 2023, 16:44
MNMD Mind Medicine (MindMed) Inc. 25 Sep 2023 2 -$20,609 4 Chief Financial Officer 25 Sep 2023, 21:30
MNMD Mind Medicine (MindMed) Inc. 25 Aug 2023 1 -$76,000 4 Chief Financial Officer 28 Aug 2023, 20:01
MNMD Mind Medicine (MindMed) Inc. 27 Jun 2023 2 -$37,194 4 Chief Financial Officer 27 Jun 2023, 18:53
MNMD Mind Medicine (MindMed) Inc. 14 Mar 2023 1 $0 4/A Chief Financial Officer 24 Apr 2023, 19:34
MNMD Mind Medicine (MindMed) Inc. 23 May 2022 2 $0 4/A Chief Financial Officer 03 Jun 2022, 16:06
MNMD Mind Medicine (MindMed) Inc. 23 May 2022 0 $0 3 Chief Financial Officer 23 May 2022, 17:01
AVTX Avalo Therapeutics, Inc. 10 Dec 2021 1 +$3,503 4 CFO 14 Dec 2021, 16:13
AVTX Cerecor Inc. 10 Jun 2021 1 +$1,747 4 CFO 14 Jun 2021, 17:03